PHI vs VEON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

PHI

53.1
AI Score
VS
PHI Wins

VEON

40.7
AI Score

Investment Advisor Scores

PHI

53score
Recommendation
BUY

VEON

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PHI VEON Winner
Forward P/E 7.3529 8.4317 PHI
PEG Ratio 2.7001 2.2274 VEON
Revenue Growth 2.1% 16.9% VEON
Earnings Growth -14.0% -78.9% PHI
Tradestie Score 53.1/100 40.7/100 PHI
Profit Margin 13.1% 1.2% PHI
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD PHI

Relative Price Performance (Last 90 Days)

PHI 1M: +0.4% · 3M: +2.9% VEON 1M: +14.2% · 3M: +4.7%

Current Technical Phase

PHI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.1% over 20 days), RSI 51

RSI (14): 51.1 · Price: $19.38

VEON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.7% over 20 days), RSI 70

RSI (14): 69.9 · Price: $59.38

Fundamentals Snapshot

Metric PHI VEON
Market Cap
Forward P/E 7.2 7.2
Trailing P/E 9.1 56.4
Revenue (TTM)
Revenue Growth 0.0% 0.2%
Gross Margin 0.7% 0.9%
Operating Margin 0.3% 0.3%
EPS 2.09 1.00
Dividend Yield 0.08%

Frequently Asked Questions

Based on our detailed analysis, PHI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.